Self‐Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon‐γ Blockade
Authors:
- 23 December 2015
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (1) , 229-236
Abstract
Objective: Resistance of Teff cells to Treg cell–mediated suppression contributes to the breakdown of peripheral tolerance in the inflamed joints of patients with juvenile idiopathic arthritis (JIA). However, unanswered questions are whether this resistant phenotype is self‐sustained and whether CD8+ and CD4+ Teff cells share the same mechanism of resistance to suppression. We undertook this study to investigate intrinsic resistance of CD8+ Teff cells to suppression and to determine how this can be targeted therapeutically.Methods: CD8+ or CD4+ Teff cells were cultured with or without antigen‐presenting cells (APCs) in Treg cell–dependent and –independent suppression assays. Synovial fluid (SF)–derived Teff cells were crosscultured with peripheral blood (PB) Treg cells from JIA patients or healthy controls. Tumor necrosis factor (TNF) or interferon‐γ (IFNγ) blocking agents were used to restore Teff cell responsiveness to suppression.Results: Suppression of cell proliferation and cytokine production in CD8+ Teff cells from the SF of JIA patients was severely impaired compared to that in CD8+ Teff cells from the PB of JIA patients, regardless of the presence of APCs and CD4+ Teff cells. Similar to CD4+ Teff cells, impaired suppression of CD8+ Teff cells was shown to be an intrinsic feature of this cell population. While TNF blockade restored both CD8+ and CD4+ Teff cell susceptibility to suppression, autocrine release of IFNγ selectively sustained CD8+ Teff cell resistance, which could be relieved by IFNγ blockade.Conclusion: Unlike CD4+ Teff cells, resistance of CD8+ Teff cells to suppression at the site of autoimmune inflammation is maintained by autocrine release of IFNγ, and blockade of IFNγ restores CD8+ Teff cell responsiveness to suppression. These findings indicate a potential therapeutic value of blocking IFNγ to restore immune regulation in JIA.Keywords
Funding Information
- European Union Seventh Framework Programme (Project EUtrain) (FP7-PEOPLE-2011-ITN)
- European Union Seventh Framework Programme (Marie Curie Action: Initial Training Networks) (FP7-PEOPLE-2011-ITN, 289903)
- Vidi grant from The Netherlands Organization for Scientific Research
- Dutch Arthritis Foundation
This publication has 15 references indexed in Scilit:
- Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritisNature Medicine, 2013
- T cells out of control—impaired immune regulation in the inflamed jointNature Reviews Rheumatology, 2012
- Rheumatoid arthritis: From autoimmunity to synovitis and joint destructionJournal of Autoimmunity, 2012
- Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cellsBlood, 2011
- Impaired suppression of synovial fluid CD4+CD25− T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cellsArthritis & Rheumatism, 2011
- The inflammatory milieu in the rheumatic joint reduces regulatory T‐cell functionEuropean Journal of Immunology, 2011
- Regulatory T cells and inhibitory cytokines in autoimmunityCurrent Opinion in Immunology, 2009
- Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humansNature Reviews Immunology, 2007
- Regulation of immunity by self-reactive T cellsNature, 2005
- CD4+CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluidArthritis & Rheumatism, 2004